+1-888-308-5802     
News Contact Us

Arctic Visions, University of Hong Kong to develop glaucoma therapies

Author : Pankaj Singh | Published Date : 2021-07-06 

China-based clinical-stage ophthalmology firm Arctic Vision recently announced it has entered a research and development deal with Prof. Christopher Leung, Head and Clinical Professor at the HKU (University of Hong Kong) Ophthalmology department, for neuroprotective therapies to treat glaucoma.

For the record, glaucoma, an optic neuropathy defined by the gradual loss of retinal ganglion cells (RGCs), is the leading cause of permanent blindness. It impacted 76 million people worldwide in 2020, with about 22 million in China alone.

It is to be noted that Neuroprotection, which is conducted as non-intraocular pressure (IOP)-related therapies to stop or slow down glaucomatous neurodegeneration, is still an unmet demand in glaucoma management. Thus, new techniques to prevent glaucoma-related blindness are required urgently.

The latest collaboration between HKU and Arctic Vision aims to develop medicines for the treatment of glaucoma with a novel mode of action.

Arctic Vision and HKU, with this four-year collaboration, will focus on modifying mitochondrial activity as a neuroprotective approach and altering cellular pathways in retinal ganglion cells (RGCs) for neuro-regeneration and neuroprotection. Besides, they will also develop a gene therapy based on microRNA for the protection of optic nerve in the patients of glaucoma, cited sources close to the matter.

The research will be funded by Arctic Vision, to develop in vivo experimental glaucoma models and undertake a Phase I clinical study.

In this context, Dr. Eddy (Hoi Ti) Wu, CEO, Board Director, and Founder of Arctic Vision, expressed they will collaborate closely with Professor Leung, to develop innovative neuroprotection strategies for glaucoma patients who have progressive vision loss despite effective IOP treatment.

Commenting on the collaboration, Prof. Christopher Leung mentioned they are thrilled to receive funding from Arctic Vision to continue their research into glaucoma treatment. The partnership will also help Hong Kong train vision scientists and biomedical engineers, he added.

About HKU

With 10 faculties and a commitment to intellectual independence, liberty, and diversity, the University of Hong Kong (HKU) enjoys a global reputation as a research-led comprehensive university.

Source Credit –

https://www.prnewswire.com/news-releases/arctic-vision-joins-forces-with-the-university-of-hong-kong-department-of-ophthalmology-to-discover-and-develop-novel-neuroprotective-therapies-for-ocular-disease-301325350.html

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Kennon Robotics bags USD 200 million to expand into unexplored markets

Published Date: 2021-09-17         Author: Pankaj Singh

Shanghai-based service robotics company Keenon Robotics Co. Ltd. has reportedly raised USD 200 million in a Series D funding round which was led by Softbank Vision Fund 2. This is considered to be the largest funding to date in the service robot business space. The funding round also saw particip... Read More

U.S. regulator seeks data from 12 automakers for Tesla Autopilot probe

Published Date: 2021-09-16         Author: Pankaj Singh

The National Highway Traffic Safety Administration (NHTSA), recently requested 12 major automakers for aid as a part of the investigation into crashes involving Tesla cars into other vehicles while using its advanced driver assistance system (ADAS), the Tesla Autopilot. It is to be noted that Tesla... Read More

Battery Ventures acquires Goodfellow to expand its product portfolio

Published Date: 2021-09-15         Author: Pankaj Singh

Boston-based venture capital firm Battery Ventures recently revealed to have acquired Goodfellow Cambridge Ltd., a specialty provider of superior quality materials for R&D, prototyping, and specialized manufacturing. Goodfellow, based in Cambridgeshire, U.K., also has subsidiaries in France, ... Read More

© 2021 Fractovia. All Rights Reserved